摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-Pyrimidin-4-yl-6-(3-trifluoromethyl-phenyl)-pyridazin-3-ol | 853730-41-3

中文名称
——
中文别名
——
英文名称
5-Pyrimidin-4-yl-6-(3-trifluoromethyl-phenyl)-pyridazin-3-ol
英文别名
——
5-Pyrimidin-4-yl-6-(3-trifluoromethyl-phenyl)-pyridazin-3-ol化学式
CAS
853730-41-3
化学式
C15H9F3N4O
mdl
——
分子量
318.258
InChiKey
MOVHWFBOYNUOOG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.45±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.33
  • 重原子数:
    23.0
  • 可旋转键数:
    2.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    71.79
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    5-Pyrimidin-4-yl-6-(3-trifluoromethyl-phenyl)-pyridazin-3-ol苄基三乙基氯化铵potassium carbonateN,N-二异丙基乙胺三氯氧磷 作用下, 以 N-甲基吡咯烷酮 为溶剂, 反应 20.0h, 生成 2-methyl-3-phenyl-1-N-[5-pyrimidin-4-yl-6-[3-(trifluoromethyl)phenyl]pyridazin-3-yl]propane-1,2-diamine
    参考文献:
    名称:
    Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase
    摘要:
    Novel potent trisubstituted pyridazine inhibitors of p38 MAP (mitogen activated protein) kinase are described that have activity in both cell-based assays of cytokine release and animal models of rheumatoid arthritis. They demonstrated potent inhibition of LPS-induced TNF-alpha production in mice and exhibited good efficacy in the rat collagen induced arthritis model.
    DOI:
    10.1016/j.bmcl.2005.02.010
  • 作为产物:
    描述:
    参考文献:
    名称:
    Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase
    摘要:
    Novel potent trisubstituted pyridazine inhibitors of p38 MAP (mitogen activated protein) kinase are described that have activity in both cell-based assays of cytokine release and animal models of rheumatoid arthritis. They demonstrated potent inhibition of LPS-induced TNF-alpha production in mice and exhibited good efficacy in the rat collagen induced arthritis model.
    DOI:
    10.1016/j.bmcl.2005.02.010
点击查看最新优质反应信息